These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 26499490)
1. Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells. Ravi M; Tentu S; Baskar G; Rohan Prasad S; Raghavan S; Jayaprakash P; Jeyakanthan J; Rayala SK; Venkatraman G BMC Cancer; 2015 Oct; 15():768. PubMed ID: 26499490 [TBL] [Abstract][Full Text] [Related]
2. Dillenia suffruticosa dichloromethane root extract induced apoptosis towards MDA-MB-231 triple-negative breast cancer cells. Foo JB; Saiful Yazan L; Tor YS; Wibowo A; Ismail N; Armania N; Cheah YK; Abdullah R J Ethnopharmacol; 2016 Jul; 187():195-204. PubMed ID: 27131434 [TBL] [Abstract][Full Text] [Related]
3. C-Phycocyanin exerts anti-cancer effects via the MAPK signaling pathway in MDA-MB-231 cells. Jiang L; Wang Y; Liu G; Liu H; Zhu F; Ji H; Li B Cancer Cell Int; 2018; 18():12. PubMed ID: 29416441 [TBL] [Abstract][Full Text] [Related]
4. Different mechanisms involved in the berberine-induced antiproliferation effects in triple-negative breast cancer cell lines. Lin YS; Chiu YC; Tsai YH; Tsai YF; Wang JY; Tseng LM; Chiu JH J Cell Biochem; 2019 Aug; 120(8):13531-13544. PubMed ID: 30957305 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, Crystal Study, and Anti-Proliferative Activity of Some 2-Benzimidazolylthioacetophenones towards Triple-Negative Breast Cancer MDA-MB-468 Cells as Apoptosis-Inducing Agents. Abdel-Aziz HA; Eldehna WM; Ghabbour H; Al-Ansary GH; Assaf AM; Al-Dhfyan A Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27483243 [TBL] [Abstract][Full Text] [Related]
6. PLGA-CTAB curcumin nanoparticles: Fabrication, characterization and molecular basis of anticancer activity in triple negative breast cancer cell lines (MDA-MB-231 cells). Meena R; Kumar S; Kumar R; Gaharwar US; Rajamani P Biomed Pharmacother; 2017 Oct; 94():944-954. PubMed ID: 28810532 [TBL] [Abstract][Full Text] [Related]
7. C-Phycocyanin elicited antitumor efficacy via cell-cycle arrest, apoptosis induction, and invasion inhibition in esophageal squamous cell carcinoma. Zhang X; Fan T; Li S; Guan F; Zhang J; Liu H J Recept Signal Transduct Res; 2019 Apr; 39(2):114-121. PubMed ID: 31322033 [No Abstract] [Full Text] [Related]
8. Molecular mechanisms in C-Phycocyanin induced apoptosis in human chronic myeloid leukemia cell line-K562. Subhashini J; Mahipal SV; Reddy MC; Mallikarjuna Reddy M; Rachamallu A; Reddanna P Biochem Pharmacol; 2004 Aug; 68(3):453-62. PubMed ID: 15242812 [TBL] [Abstract][Full Text] [Related]
10. Marine natural compound cyclo(L-leucyl-L-prolyl) peptide inhibits migration of triple negative breast cancer cells by disrupting interaction of CD151 and EGFR signaling. Kgk D; Kumari S; G S; Malla RR Chem Biol Interact; 2020 Jan; 315():108872. PubMed ID: 31669320 [TBL] [Abstract][Full Text] [Related]
11. Anti-metastatic and anti-proliferative activity of eugenol against triple negative and HER2 positive breast cancer cells. Abdullah ML; Hafez MM; Al-Hoshani A; Al-Shabanah O BMC Complement Altern Med; 2018 Dec; 18(1):321. PubMed ID: 30518369 [TBL] [Abstract][Full Text] [Related]
12. Antiproliferative and antimetastatic properties of 3-benzyloxy-16-hydroxymethylene-estradiol analogs against breast cancer cell lines. Sinka I; Kiss A; Mernyák E; Wölfling J; Schneider G; Ocsovszki I; Kuo CY; Wang HC; Zupkó I Eur J Pharm Sci; 2018 Oct; 123():362-370. PubMed ID: 30010030 [TBL] [Abstract][Full Text] [Related]
13. Flavonoid calycopterin triggers apoptosis in triple-negative and ER-positive human breast cancer cells through activating different patterns of gene expression. Moradi M; Gholipour H; Sepehri H; Attari F; Delphi L; Arefian E; Moridi Farimani M Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2145-2156. PubMed ID: 32617603 [TBL] [Abstract][Full Text] [Related]
14. New (E)-1-alkyl-1H-benzo[d]imidazol-2-yl)methylene)indolin-2-ones: Synthesis, in vitro cytotoxicity evaluation and apoptosis inducing studies. Sharma P; Thummuri D; Reddy TS; Senwar KR; Naidu VGM; Srinivasulu G; Bharghava SK; Shankaraiah N Eur J Med Chem; 2016 Oct; 122():584-600. PubMed ID: 27448916 [TBL] [Abstract][Full Text] [Related]
15. Berberine activates caspase-9/cytochrome c-mediated apoptosis to suppress triple-negative breast cancer cells in vitro and in vivo. Zhao Y; Jing Z; Lv J; Zhang Z; Lin J; Cao X; Zhao Z; Liu P; Mao W Biomed Pharmacother; 2017 Nov; 95():18-24. PubMed ID: 28826092 [TBL] [Abstract][Full Text] [Related]
16. Deciphering the molecular mechanism underlying anticancer activity of coumestrol in triple-negative breast cancer cells. Zafar A; Singh S; Satija YK; Saluja D; Naseem I Toxicol In Vitro; 2018 Feb; 46():19-28. PubMed ID: 28986287 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and apoptosis inducing effect of novel (Z)-3-(3'-methoxy-4'-(2-amino-2-oxoethoxy)-benzylidene)indolin-2-ones as potential antitumour agents. Senwar KR; Reddy TS; Thummuri D; Sharma P; Naidu VG; Srinivasulu G; Shankaraiah N Eur J Med Chem; 2016 Aug; 118():34-46. PubMed ID: 27128173 [TBL] [Abstract][Full Text] [Related]
18. A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer. Sambi M; Samuel V; Qorri B; Haq S; Burov SV; Markvicheva E; Harless W; Szewczuk MR Drug Des Devel Ther; 2020; 14():1995-2019. PubMed ID: 32546966 [TBL] [Abstract][Full Text] [Related]
19. Platinum complexes inhibit HER-2 enriched and triple-negative breast cancer cells metabolism to suppress growth, stemness and migration by targeting PKM/LDHA and CCND1/BCL2/ATG3 signaling pathways. Bai X; Ali A; Lv Z; Wang N; Zhao X; Hao H; Zhang Y; Rahman FU Eur J Med Chem; 2021 Nov; 224():113689. PubMed ID: 34293698 [TBL] [Abstract][Full Text] [Related]
20. Ad-p53 enhances the sensitivity of triple-negative breast cancer MDA-MB-468 cells to the EGFR inhibitor gefitinib. Wang X; Song H; Yu Q; Liu Q; Wang L; Liu Z; Yu Z Oncol Rep; 2015 Feb; 33(2):526-32. PubMed ID: 25501339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]